Entrada Therapeutics, Inc. (TRDA)
10.59
-0.45
(-4.08%)
USD |
NASDAQ |
Dec 09, 16:00
10.57
-0.02
(-0.19%)
After-Hours: 20:00
Entrada Therapeutics EPS Diluted (Quarterly): -1.064 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Janux Therapeutics, Inc. | -0.392 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -44.13M |
| Revenue (Quarterly) | 1.614M |
| Total Expenses (Quarterly) | 45.75M |
| Enterprise Value | 130.30M |
| Gross Profit Margin (Quarterly) | 25.65% |
| Profit Margin (Quarterly) | -2.73K% |
| Earnings Yield | -23.64% |
| Normalized Earnings Yield | -23.33 |